Ugrás a tartalomhoz

vortioxetine

A Wikiszótárból, a nyitott szótárból
vortioxetine
Clinical data
Pronunciation/vɔːrtiˈɒksətn/ vor-tee-OK-sə-teen
Trade namesTrintellix, Brintellix, others
Other namesLu AA21004, Vortioxetine hydrobromide (JAN JP), Vortioxetine hydrobromide (USAN US)
AHFS/Drugs.comMonograph
MedlinePlusa614003
License data
Pregnancy
category
  • AU: B3
Routes of
administration
By mouth
Drug classSerotonin modulator and stimulator (SMS)
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only)
  • BR: Class C1 (Other controlled substances)
  • CA: ℞-only
  • UK: POM (Prescription only)
  • US: ℞-only
  • EU: Rx-only
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability75% (peak at 7–11 hours)
Protein binding98–99%
MetabolismLiver, primarily CYP2D6-mediated oxidation
Elimination half-life66 hours
Excretion59% in urine, 26% in feces
Identifiers
  • 1-[2-(2,4-Dimethyl-phenylsulfanyl)phenyl]piperazine
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
Chemical and physical data
FormulaC18H22N2S
Molar mass298.448 g·mol−1
3D model (JSmol)
  • CC(C=C(C)C=C1)=C1SC2=C(N3CCNCC3)C=CC=C2
  • InChI=1S/C18H22N2S/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20/h3-8,13,19H,9-12H2,1-2H3 ☒N
  • Key:YQNWZWMKLDQSAC-UHFFFAOYSA-N ☒N
  (verify)


Főnév

vortioxetine (tsz. vortioxetines)

  1. (gyógyszertan) vortioxetin